Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines

Authors:

Abstract
No abstract available
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB 643 (C1))

This publication has 60 references indexed in Scilit: